Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VRDNViridian Therapeutics, Inc.\DE

Nasdaq · CIK 0001590750
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts430

Identity from submissions API

NameViridian Therapeutics, Inc.\DE
CIK0001590750
TickersVRDN
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN471187261
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617.272.4600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MIRAGEN THERAPEUTICS, INC. (2017-02-13T05:00:00.000Z → 2021-01-15T05:00:00.000Z)
  • SIGNAL GENETICS, INC. (2013-12-06T05:00:00.000Z → 2017-02-10T05:00:00.000Z)
  • SIGNAL GENETICS LLC (2013-11-12T05:00:00.000Z → 2014-07-09T04:00:00.000Z)
Business address
221 CRESCENT STREET
SUITE 103A
WALTHAM
MA
02453
MA
Mailing address
221 CRESCENT STREET
SUITE 103A
WALTHAM
MA
02453
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

821 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128315 005-88625 261560964 34 12744
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000699 005-88625 261556454 34 8134
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000744 005-88625 261538396 34 8349
2026-11-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-452665 001-36483 261533829 34 182834 1 1
2026-11-04 10-Q 10-Q 0001590750-26-000022 001-36483 261520052 34 12175867 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-446200 001-36483 261520028 34 233660 1 1
2026-08-20 4 4 0001193125-26-359636 10199
2026-08-20 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005637 005-88625 261300029 34 17875
2026-08-19 144 xsl144X01/primary_doc.xml 0001959173-26-006222 001-36483 261294670 33 5704
2026-08-18 4 4 0001193125-26-355735 7011
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097208 005-88625 261282228 34 12893
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001907884-26-000016 005-88625 261278666 34 9764
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000556 005-88625 261277480 34 7924
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003486 005-88625 261276430 34 11752
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000558 005-88625 261252435 34 8378
2026-08-06 10-Q 10-Q 0001590750-26-000018 001-36483 261246006 34 17942835 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336691 001-36483 261245901 34 215309 1 1
2026-07-02 4 4 0001193125-26-294561 6428
2026-07-02 4 4 0001193125-26-294560 5762
2026-07-02 4 4 0001193125-26-294556 5766
2026-07-02 4 4 0001193125-26-294552 5797
2026-07-02 4 4 0001193125-26-294547 6420
2026-07-02 4 4 0001193125-26-294546 5726
2026-06-29 8-K 8-K 7.01,8.01,9.01 0001193125-26-286273 001-36483 261130863 34 184411 1 1
2026-06-26 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-078245 005-88625 261129005 34 17037
2026-06-03 8-K 8-K 5.07 0001193125-26-254560 001-36483 261058897 34 160228 1 1
2026-05-28 8-K 8-K 1.02 0001193125-26-245186 001-36483 261035532 34 149575 1 1
2026-05-26 8-K 8-K 1.01 0001193125-26-239246 001-36483 261019706 34 151050 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062332 005-88625 26985872 34 9626
2026-05-13 4 OWNERSHIP DOCUMENT 0001104659-26-060294 9943
2026-05-13 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-060292 005-88625 26973891 34 14586
2026-05-11 8-K 8-K 1.01,2.03,8.01,9.01 0001193125-26-216709 001-36483 26963034 34 2125490 1 1
2026-05-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-001638 005-88625 26958624 34 11568
2026-05-08 424B5 424B5 0001193125-26-214614 333-290056 26958296 33 1383861 1 1
2026-05-08 424B5 424B5 0001193125-26-214607 333-290056 26958242 33 2372678 1 1
2026-05-07 FWP FWP 0001193125-26-210127 333-290056 26950597 34 19076
2026-05-07 FWP FWP 0001193125-26-210124 333-290056 26950589 34 57275
2026-05-07 305B2 305B2 0001193125-26-210120 333-290056 26950573 33 237296
2026-05-06 424B5 424B5 0001193125-26-207208 333-290056 26945519 33 1236527
2026-05-06 424B5 424B5 0001193125-26-207203 333-290056 26945511 33 2248588
2026-05-05 FWP FWP 0001193125-26-206789 333-290056 26944666 34 17446
2026-05-05 8-K 8-K 7.01,9.01 0001193125-26-205099 001-36483 26940501 34 28856538 1 1
2026-05-05 10-Q 10-Q 0001590750-26-000012 001-36483 26940398 34 6615546 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-205010 001-36483 26940396 34 230802 1 1
2026-04-17 ARS ARS 0001193125-26-160354 001-36483 26869464 34 2935085
2026-04-17 DEFA14A DEFA14A 0001193125-26-160349 001-36483 26869453 34 185410
2026-04-17 DEF 14A DEF 14A 0001193125-26-160344 001-36483 26869442 34 4034136 1 1
2026-03-30 8-K 8-K 7.01,9.01 0001193125-26-130433 001-36483 26810007 34 8810185 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002586 005-88625 26805165 34 7431
2026-03-09 4/A 4/A 0001193125-26-099023 5217
2026-03-09 4/A 4/A 0001193125-26-099014 5270
2026-03-09 4/A 4/A 0001193125-26-099008 5188
2026-03-09 4/A 4/A 0001193125-26-099007 5353
2026-03-04 4 4 0001193125-26-092074 13126
2026-03-04 4 4 0001193125-26-092071 13565
2026-03-04 4/A 4/A 0001193125-26-092068 4531
2026-03-04 4/A 4/A 0001193125-26-092065 4441
2026-03-04 4 4 0001193125-26-092040 13581
2026-03-04 4 4 0001193125-26-092036 13607
2026-03-04 4 4 0001193125-26-092028 8074
2026-03-04 144 xsl144X01/primary_doc.xml 0001959173-26-001932 001-36483 26721803 33 4861
2026-03-04 144 xsl144X01/primary_doc.xml 0001959173-26-001929 001-36483 26721709 33 5408
2026-03-04 144 xsl144X01/primary_doc.xml 0001959173-26-001925 001-36483 26721597 33 4809
2026-03-04 144 xsl144X01/primary_doc.xml 0001959173-26-001921 001-36483 26721320 33 5018
2026-02-26 S-8 S-8 0001193125-26-076844 333-293795 26689301 33 228883 1 1
2026-02-26 10-K 10-K 0001590750-26-000007 001-36483 26681711 34 12798192 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-073391 001-36483 26681688 34 240774 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001907884-26-000004 005-88625 26638993 34 9695
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000723 005-88625 26629133 34 11684
2026-01-02 4 4 0001193125-26-001097 4896
2025-12-31 144 xsl144X01/primary_doc.xml 0001959173-25-007945 001-36483 251616540 33 5677
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000032 005-88625 251488224 34 11839
2025-11-05 10-Q 10-Q 0001590750-25-000020 001-36483 251451843 34 10302380 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265711 001-36483 251451757 34 251310 1 1
2025-10-27 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-102608 005-88625 251420282 34 23605
2025-10-27 4 OWNERSHIP DOCUMENT 0001104659-25-102606 9660
2025-10-23 8-K 8-K 1.01,9.01 0001193125-25-247410 001-36483 251411260 34 494995 1 1
2025-10-23 424B5 424B5 0001193125-25-247409 333-290056 251411258 33 727282 1 1
2025-10-21 424B5 424B5 0001193125-25-245209 333-290056 251407497 33 602057
2025-10-21 8-K 8-K 2.02 0001193125-25-245206 001-36483 251407483 34 145779 1 1
2025-10-20 8-K 8-K 1.01 0001193125-25-243039 001-36483 251402331 34 155726 1 1
2025-09-05 S-3ASR S-3ASR 0001193125-25-196564 333-290056 251295003 33 771084 1 1
2025-08-06 S-8 S-8 0001193125-25-174447 333-289291 251189496 33 351771 1 1
2025-08-06 10-Q 10-Q 0001590750-25-000012 001-36483 251187425 34 8077000 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001193125-25-173983 001-36483 251187398 34 255770 1 1
2025-07-30 8-K 8-K 1.01,7.01,9.01 0001193125-25-168614 001-36483 251163941 34 176946 1 1
2025-07-02 4 4 0000950170-25-093118 6291
2025-07-02 4 4 0000950170-25-093111 6283
2025-07-02 4 4 0000950170-25-093107 5586
2025-07-02 4 4 0000950170-25-093102 5613
2025-07-02 4 4 0000950170-25-093099 5599
2025-07-02 4 4 0000950170-25-093098 5626
2025-06-24 8-K 8-K 5.02,5.07,9.01 0001193125-25-145741 001-36483 251069384 34 397176 1 1
2025-06-11 4 OWNERSHIP DOCUMENT 0001104659-25-058580 16881
2025-05-20 8-K 8-K 7.01,9.01 0001193125-25-122821 001-36483 25966148 34 1990169 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-003251 005-88625 25950283 34 9555
2025-05-06 10-Q 10-Q 0001590750-25-000008 001-36483 25915291 34 7868664 1 1
2025-05-06 8-K 8-K 2.02,9.01 0001193125-25-113291 001-36483 25915239 34 231172 1 1
2025-04-25 ARS ARS 0001193125-25-095022 001-36483 25870025 34 54333191
2025-04-25 DEFA14A DEFA14A 0001193125-25-095018 001-36483 25870022 34 1040354
2025-04-25 DEF 14A DEF 14A 0001193125-25-095008 001-36483 25870018 34 4378505 1 1
2025-04-11 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-003888 005-88625 25833597 34 17712
2025-04-09 4 4 0000950170-25-052530 5580
2025-04-09 3 3 0000950170-25-052524 14795
2025-04-07 8-K 8-K 5.02,7.01,9.01 0001193125-25-073937 001-36483 25816356 34 178502 1 1
2025-03-12 4 4 0000950170-25-038004 5664
2025-03-12 3 3 0000950170-25-037980 15500
2025-03-12 4 4 0000950170-25-037965 6265
2025-03-12 3 3 0000950170-25-037958 14112
2025-03-10 8-K 8-K 5.02 0001193125-25-050880 001-36483 25723810 34 155567 1 1
2025-03-04 4 4 0000950170-25-032908 8106
2025-03-04 4 4 0000950170-25-032891 8235
2025-03-04 4 4 0000950170-25-032887 8152
2025-03-04 4 4 0000950170-25-032884 19236
2025-03-04 424B5 424B5 0001193125-25-044400 333-267351 25701309 33 515785 1 1
2025-03-04 8-K 8-K 1.01,1.02,9.01 0001193125-25-044406 001-36483 25700545 34 417091 1 1
2025-03-03 S-8 S-8 0001193125-25-044166 333-285505 25698608 33 317014 1 1
2025-03-03 10-K 10-K 0001590750-25-000004 001-36483 25693793 34 11660063 1 1
2025-02-27 8-K 8-K 2.02,9.01 0001193125-25-037586 001-36483 25672975 34 257448 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004228 005-88625 25631538 34 25711
2025-01-10 8-K 8-K 5.02 0001193125-25-004435 001-36483 25522876 34 156225 1 1
2024-12-16 8-K 8-K 7.01,8.01,9.01 0001193125-24-279021 001-36483 241550131 34 222059 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119344 005-88625 241464817 34 60139
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119339 005-88625 241464806 34 155617
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258738 005-88625 241463743 34 60864
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119033 005-88625 241463302 34 74246
2024-11-12 10-Q 10-Q 0001590750-24-000023 001-36483 241443252 34 10410874 1 1
2024-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-24-255130 001-36483 241443251 34 5929345 1 1
2024-10-18 SC 13G/A Viridian_Therapeutics_Inc.htm 0000093751-24-000893 005-88625 241379671 34 56281
2024-09-30 4 4 0000950170-24-110485 16253
2024-09-30 4 4 0000950170-24-110484 16027
2024-09-17 4 OWNERSHIP DOCUMENT 0001104659-24-100769 9674
2024-09-17 SC 13D/A SC 13D/A 0001104659-24-100768 005-88625 241306009 34 74393
2024-09-13 424B5 424B5 0001193125-24-218405 333-267351 241296391 33 743750 1 1
2024-09-12 8-K 8-K 1.01,9.01 0001193125-24-218131 001-36483 241295836 34 497706 1 1
2024-09-10 424B5 424B5 0001193125-24-216641 333-267351 241290388 33 573214
2024-09-10 8-K 8-K 7.01,8.01,9.01 0001193125-24-216321 001-36483 241288741 34 225673 1 1
2024-08-12 S-8 S-8 0001193125-24-198865 333-281478 241196770 33 668579 1 1
2024-08-08 8-K 8-K 2.02,9.01 0001193125-24-196513 001-36483 241186213 34 240159 1 1
2024-08-08 10-Q 10-Q 0001590750-24-000019 001-36483 241186140 34 7800240 1 1
2024-07-15 8-K 8-K 7.01,9.01 0001193125-24-178820 001-36483 241115826 34 13820733 1 1
2024-06-28 4 4 0000950170-24-079084 15629
2024-06-28 4 4 0000950170-24-079038 15494
2024-06-28 4 4 0000950170-24-079037 15624
2024-06-28 4 4 0000950170-24-079044 16201
2024-06-28 4 4 0000950170-24-079042 16313
2024-06-20 8-K 8-K 5.02,5.07,9.01 0001193125-24-164461 001-36483 241056449 34 401047 1 1
2024-06-10 DEFA14A DEFA14A 0001193125-24-157914 001-36483 241031511 34 6452944
2024-05-08 10-Q 10-Q 0001590750-24-000012 001-36483 24924284 34 6992934 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001193125-24-133770 001-36483 24924220 34 225296 1 1
2024-04-26 ARS ARS 0001193125-24-115943 001-36483 24879023 34 2813578
2024-04-26 DEFA14A DEFA14A 0001193125-24-115940 001-36483 24879011 34 386343
2024-04-26 DEF 14A DEF 14A 0001193125-24-115928 001-36483 24878991 34 1004735
2024-04-16 8-K 8-K 1.01 0001193125-24-097728 001-36483 24847844 34 155660 1 1
2024-04-01 SC 13D/A SC 13D/A 0001193125-24-083710 005-88625 24811601 34 69280
2024-04-01 4 4 0000950170-24-039599 20179
2024-02-28 S-8 S-8 0001193125-24-050669 333-277453 24695420 33 129392
2024-02-27 10-K 10-K 0001590750-24-000007 001-36483 24687516 34 10913668 1 1
2024-02-27 8-K 8-K 2.02,9.01 0001193125-24-047916 001-36483 24686618 34 248701 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024204 005-88625 24641645 34 155698
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023624 005-88625 24637988 34 60618
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006629 005-88625 24637758 34 74453
2024-02-14 3 3 0000950170-24-015203 13546
2024-02-14 4 4 0000950170-24-015205 5681
2024-02-14 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0000921895-24-000433 005-88625 24633050 34 266689
2024-02-14 SC 13G/A deeptrack-vrdn123123a2.htm 0001172661-24-000950 005-88625 24632850 34 105929
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022251 005-88625 24629887 34 13420
2024-02-07 4 4 0000950170-24-012167 5625
2024-01-29 SC 13G SC 13G 0001193125-24-018239 005-88625 24574389 34 64887
2024-01-29 SC 13G/A us92790c1045_012924.txt 0001086364-24-005136 005-88625 24573125 34 14003
2024-01-24 4 4 0000950170-24-007123 13955
2024-01-24 SC 13D/A SC 13D/A 0001193125-24-014334 005-88625 24557521 34 79729
2024-01-24 SC 13G Viridian_Thera_Inc.txt 0000093751-24-000118 005-88625 24554299 34 8813
2024-01-19 8-K 8-K 1.01,2.02,8.01,9.01 0001193125-24-011355 001-36483 24546495 34 512269 1 1
2024-01-19 424B5 424B5 0001193125-24-011281 333-267351 24546046 33 585597
2024-01-17 424B5 424B5 0001193125-24-009241 333-267351 24538422 33 580377
2024-01-12 3 3 0000950170-24-004264 8063
2024-01-10 SC 13G filing.txt 0000315066-24-000026 005-88625 24524971 34 8582
2024-01-08 8-K 8-K 5.02,7.01,9.01 0001193125-24-003936 001-36483 24518435 34 208993 1 1
2023-12-18 144 xsl144X01/primary_doc.xml 0001959173-23-005568 001-36483 231492694 33 5361
2023-12-18 8-K 8-K 5.03,7.01,8.01,9.01 0001193125-23-297131 001-36483 231492276 34 10816828 1 1
2023-12-12 144 xsl144X01/primary_doc.xml 0001959173-23-005386 001-36483 231481474 33 5235
2023-12-08 SC 13G SC 13G 0001104659-23-124715 005-88625 231475635 34 67196
2023-12-07 144 xsl144X01/primary_doc.xml 0001959173-23-005265 001-36483 231472654 33 4607
2023-12-01 144 xsl144X01/primary_doc.xml 0001959173-23-005120 001-36483 231459495 33 4620
2023-11-30 S-3ASR S-3ASR 0001193125-23-286262 333-275805 231455713 33 554148
2023-11-16 144 xsl144X01/primary_doc.xml 0001959173-23-004822 001-36483 231414848 33 4649
2023-11-13 4 4 0000950170-23-063124 5579
2023-11-13 10-Q 10-Q 0001590750-23-000013 001-36483 231399254 34 8339721 1 1
2023-11-13 8-K 8-K 2.02,9.01 0001193125-23-276007 001-36483 231398624 34 243387 1 1
2023-11-03 SC 13D/A SC 13D/A 0001193125-23-270436 005-88625 231376838 34 79637
2023-11-02 8-K 8-K 5.02,5.03,9.01 0001193125-23-269415 001-36483 231372910 34 251142 1 1
2023-11-01 4 4 0000950170-23-057692 14380
2023-11-01 3 3 0000950170-23-057527 12888
2023-11-01 4 4 0000950170-23-057520 5633
2023-11-01 4 4 0000950170-23-057519 5718
2023-11-01 3 3 0000950170-23-057502 13592
2023-10-30 8-K 8-K 1.01,3.02,5.02,7.01,9.01 0001193125-23-265717 001-36483 231357526 34 719703 1 1
2023-09-25 4 4 0000950170-23-049704 5474
2023-09-25 3 3 0000950170-23-049702 13529
2023-09-25 8-K 8-K 5.02 0001193125-23-240931 001-36483 231273148 34 155651 1 1
2023-09-19 3 3 0000950170-23-048793 14769
2023-09-12 8-K 8-K 5.02 0001193125-23-233500 001-36483 231250488 34 165400 1 1
2023-08-08 S-8 S-8 0001193125-23-206349 333-273813 231152602 33 116165
2023-08-08 10-Q 10-Q 0001590750-23-000008 001-36483 231151922 34 6712044 1 1
2023-07-24 S-3ASR S-3ASR 0001193125-23-192245 333-273390 231105119 33 176831
2023-07-17 8-K 8-K 7.01,9.01 0001193125-23-187636 001-36483 231090489 34 13113435 1 1
2023-07-10 8-K 8-K 7.01,9.01 0001193125-23-184757 001-36483 231080547 34 4810362 1 1
2023-06-20 4 FORM 4 SUBMISSION 0000899243-23-015998 14895
2023-06-16 4 4 0000950170-23-028727 6216
2023-06-16 4 4 0000950170-23-028725 5557
2023-06-16 4 4 0000950170-23-028724 6192
2023-06-16 4 4 0000950170-23-028721 5516
2023-06-16 8-K 8-K 5.02,5.07,9.01 0001193125-23-169038 001-36483 231021708 34 396717 1 1
2023-06-14 SC 13D/A SC 13D/A 0001104659-23-071200 005-88625 231014278 34 73970
2023-06-06 4 FORM 4 SUBMISSION 0000899243-23-014615 21240
2023-06-02 144 xsl144X01/primary_doc.xml 0001974158-23-000010 001-36483 23989211 33 6317
2023-05-11 SC 13G SC 13G 0001104659-23-059162 005-88625 23911460 34 71139
2023-05-10 10-Q 10-Q 0001590750-23-000003 001-36483 23904233 34 6784145 1 1
2023-05-09 8-K 8-K 2.02,9.01 0001193125-23-139409 001-36483 23902074 34 232474 1 1
2023-04-28 ARS ARS 0001193125-23-124507 001-36483 23860501 34 3464685
2023-04-28 DEFA14A DEFA14A 0001193125-23-124503 001-36483 23860491 34 130401
2023-04-28 DEF 14A DEF 14A 0001193125-23-124500 001-36483 23860478 34 965205
2023-04-12 4 4 0000950170-23-012595 4710
2023-04-12 8-K 8-K 5.02 0001193125-23-098482 001-36483 23814659 34 151698 1 1
2023-03-13 4 4 0000950170-23-007570 4676
2023-03-10 S-8 S-8 0001193125-23-067723 333-270475 23724623 33 164716
2023-03-10 4 FORM 4 SUBMISSION 0000899243-23-007996 5480
2023-03-10 8-K 8-K 7.01 0001193125-23-067504 001-36483 23723331 34 151559 1 1
2023-03-09 10-K 10-K 0001590750-23-000002 001-36483 23718184 34 8386019 1 1
2023-03-08 8-K 8-K 2.02,9.01 0001193125-23-063737 001-36483 23714848 34 250776 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021896 005-88625 23631138 34 65961
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021711 005-88625 23630171 34 160276
2023-02-14 SC 13G/A schedule13g.htm 0000929638-23-000557 005-88625 23627699 34 81153
2023-02-14 SC 13G/A AMENDMENT NO. 3 0001214659-23-002282 005-88625 23627112 34 83342
2023-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-23-000522 005-88625 23624943 34 280763
2023-02-14 SC 13G/A deeptrack-vrdn123122a1.htm 0001172661-23-000860 005-88625 23623119 34 103372
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-23-010895 005-88625 23620413 34 56997
2023-02-10 4 FORM 4 SUBMISSION 0000899243-23-004595 5755
2023-02-10 4 FORM 4 SUBMISSION 0000899243-23-004593 5761
2023-02-10 4 FORM 4 SUBMISSION 0000899243-23-004592 5752
2023-02-10 4 FORM 4 SUBMISSION 0000899243-23-004588 5789
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-017255 005-88625 23604544 34 13288
2023-02-07 4 FORM 4 SUBMISSION 0000899243-23-004238 7698
2023-02-07 3 FORM 3 SUBMISSION 0000899243-23-004235 7404
2023-02-07 4/A FORM 4/A SUBMISSION 0000899243-23-004233 9901
2023-02-06 8-K 8-K 5.02,7.01,8.01,9.01 0001193125-23-024877 001-36483 23588354 34 350184 1 1
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003921 5422
2023-02-03 SC 13G us92790c1045_020323.txt 0001306550-23-007101 005-88625 23584754 34 13666
2023-01-26 SC 13G/A VRDN_SC13GA_2023.htm 0001273087-23-000068 005-88625 23558518 34 81949
2023-01-25 4 FORM 4 SUBMISSION 0000899243-23-002674 13385
2023-01-18 4 FORM 4 SUBMISSION 0000899243-23-002075 15096
2023-01-11 4 FORM 4 SUBMISSION 0000899243-23-001626 15103
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004046 001-36483 23516413 34 11115213 1 1
2022-12-22 4 FORM 4 SUBMISSION 0000899243-22-039217 15210
2022-12-19 4 FORM 4 SUBMISSION 0000899243-22-039056 15204
2022-12-14 4 FORM 4 SUBMISSION 0000899243-22-038520 15209
2022-11-16 4 FORM 4 SUBMISSION 0000899243-22-036044 9473
2022-11-14 10-Q 10-Q 0001590750-22-000012 001-36483 221380134 34 7900087 1 1
2022-09-09 S-3ASR S-3ASR 0001193125-22-241939 333-267351 221236096 33 1125008
2022-08-19 SC 13D/A SC 13D/A 0001104659-22-092995 005-88625 221181280 34 69025
2022-08-19 8-K 8-K 1.01,9.01 0001193125-22-225373 001-36483 221181276 34 484506 1 1
2022-08-19 4 OWNERSHIP DOCUMENT 0001104659-22-092992 14118
2022-08-18 424B5 424B5 0001193125-22-224163 333-260859 221177908 33 529204
2022-08-17 424B3 424B3 0001193125-22-222510 333-260859 221171854 33 8508
2022-08-16 8-K 8-K 8.01 0001193125-22-221818 001-36483 221168499 34 185082 1 1
2022-08-16 S-8 POS S-8 POS 0001193125-22-221451 333-216112 221167891 33 61241
2022-08-16 S-8 POS S-8 POS 0001193125-22-221446 333-250906 221167877 33 61241
2022-08-16 S-8 S-8 0001193125-22-221438 333-266895 221167854 33 333789
2022-08-15 424B5 424B5 0001193125-22-221225 333-260859 221165909 33 530063
2022-08-15 10-Q 10-Q 0001590750-22-000009 001-36483 221162312 34 7549100 1 1
2022-08-15 8-K 8-K 2.02,7.01,9.01 0001193125-22-220539 001-36483 221162282 34 24204337 1 1
2022-08-12 SC 13G/A SC 13G/A 0001193125-22-219685 005-88625 221159002 34 139636
2022-06-24 3 FORM 3 SUBMISSION 0000899243-22-024060 8612
2022-06-23 8-K 8-K 5.02,7.01,9.01 0001193125-22-179235 001-36483 221033566 34 261018 1 1
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021804 5755
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021803 6390
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021802 6414
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021801 5711
2022-06-10 8-K 8-K 5.07 0001193125-22-171469 001-36483 221007611 34 161861 1 1
2022-06-02 4 FORM 4 SUBMISSION 0000899243-22-020717 5418
2022-05-31 SC 13G VRDN_SC13G.htm 0001273087-22-000073 005-88625 22984033 34 81906
2022-05-19 SC 13G formsc13g.htm 0001493152-22-014492 005-88625 22943422 34 75849
2022-05-13 10-Q 10-Q 0001590750-22-000007 001-36483 22920227 34 5776023 1 1
2022-05-12 8-K 8-K 2.02,7.01,9.01 0001193125-22-148808 001-36483 22918848 34 9461035 1 1
2022-05-04 4 FORM 4 SUBMISSION 0000899243-22-016657 5417
2022-04-27 DEFA14A DEFA14A 0001193125-22-123918 001-36483 22860946 34 129184
2022-04-27 DEF 14A DEF 14A 0001193125-22-123908 001-36483 22860898 34 626347
2022-04-05 4 FORM 4 SUBMISSION 0000899243-22-013858 7444
2022-04-05 8-K 8-K 1.01,2.03,9.01 0001193125-22-095676 001-36483 22805344 34 616426 1 1
2022-03-11 S-8 S-8 0001193125-22-073424 333-263490 22733417 33 144859
2022-03-11 10-K 10-K 0001590750-22-000004 001-36483 22731204 34 9053677 1 1
2022-03-10 8-K 8-K 2.02,9.01 0001193125-22-071962 001-36483 22729243 34 184091 1 1
2022-03-03 4 FORM 4 SUBMISSION 0000899243-22-009096 7445
2022-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT # 2 0000899140-22-000313 005-88625 22633057 34 44907
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022885 005-88625 22632413 34 148261
2022-02-14 SC 13G/A VIRIDIAN THERAPEUTICS, INC. 0001104659-22-022788 005-88625 22631929 34 84540
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022693 005-88625 22631420 34 85225
2022-02-14 SC 13G/A schedule13g.htm 0000929638-22-000476 005-88625 22630151 34 82726
2022-02-14 SC 13G/A viridian13ga3.htm 0000935836-22-000158 005-88625 22629836 34 59865
2022-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-22-000536 005-88625 22629110 34 283159
2022-02-14 SC 13G/A VIRIDIAN THERAPEUTICS, INC. 0001104659-22-021234 005-88625 22624679 34 140265
2022-02-14 SC 13G SC 13G 0001104659-22-021110 005-88625 22624574 34 67209
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-037097 005-88625 22621273 34 123104
2022-02-04 SC 13G/A SEC SCHEDULE 13G 0001678858-22-000004 005-88625 22591023 34 19095
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004673 5749
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004669 9811
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004666 5786
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004665 11891
2022-01-28 SC 13G/A SC 13G/A 0001193125-22-021341 005-88625 22567174 34 140601
2022-01-03 4 FORM 4 SUBMISSION 0000899243-22-000130 5784
2021-12-10 4 FORM 4 SUBMISSION 0000899243-21-047801 11415
2021-11-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-11-17 16:00:00 9999999995-21-004387 333-260859 211422480 33 2052
2021-11-15 CORRESP filename1.htm 0001193125-21-329814 7379
2021-11-10 UPLOAD filename1.pdf 0000000000-21-013676 40583
2021-11-08 8-K 8-K 8.01 0001193125-21-322459 001-36483 211386723 34 154942 1 1
2021-11-08 S-3 S-3 0001193125-21-322455 333-260859 211386718 33 1098965
2021-11-05 10-Q 10-Q 0001590750-21-000075 001-36483 211382203 34 21959586 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001193125-21-320169 001-36483 211380217 34 290724 1 1
2021-10-28 SC 13G d8999397_13-g.htm 0000919574-21-006456 005-88625 211354391 34 164905
2021-10-14 SC 13G SC 13G 0001104659-21-126221 005-88625 211323428 34 194832
2021-10-08 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000399 005-88625 211313943 34 33099
2021-10-04 3 FORM 3 SUBMISSION 0000899243-21-038873 9953
2021-09-30 SC 13G SCHEDULE 13G 0001213900-21-050795 005-88625 211295392 34 50766
2021-09-29 SC 13G/A viridiantherapeutics13ga.htm 0000935836-21-000547 005-88625 211289651 34 61383
2021-09-29 SC 13G/A AMENDMENT NO. 2 0001214659-21-009866 005-88625 211289111 34 42195
2021-09-28 4 FORM 4 SUBMISSION 0001209191-21-058002 9306
2021-09-24 SC 13G deeptrack-vrdn092121.htm 0001172661-21-001921 005-88625 211278062 34 103354
2021-09-24 SC 13G/A AMENDMENT NO. 1 0001214659-21-009771 005-88625 211276700 34 42345
2021-09-23 SC 13D/A SC 13D/A 0001193125-21-280732 005-88625 211272858 34 77453
2021-09-23 8-K 8-K 1.01,5.03,9.01 0001193125-21-280729 001-36483 211272855 34 527792 1 1
2021-09-23 4 FORM 4 SUBMISSION 0000899243-21-037255 17598
2021-09-22 424B5 424B5 0001193125-21-279564 333-237413 211270319 33 519324
2021-09-20 424B5 424B5 0001193125-21-277298 333-237413 211263362 33 524710
2021-09-10 SC 13G p99210sc13g.htm 0001214659-21-009381 005-88625 211245774 34 42241
2021-08-26 3 FORM 3 SUBMISSION 0001209191-21-053427 8267
2021-08-26 SC 13G SCHEDULE 13G 0001193125-21-257239 005-88625 211210930 34 151963
2021-08-12 10-Q 10-Q 0001590750-21-000070 001-36483 211165859 34 6830180 1 1
2021-08-11 8-K 8-K 2.02,9.01 0001193125-21-242625 001-36483 211161960 34 386524 1 1
2021-07-27 4 FORM 4 SUBMISSION 0000899243-21-030131 5698
2021-07-27 3 FORM 3 SUBMISSION 0000899243-21-030127 7259
2021-07-27 3 PRIMARY DOCUMENT 0000950123-21-009252 7194
2021-07-26 8-K 8-K 5.02,8.01,9.01 0001193125-21-223656 001-36483 211112378 34 261998 1 1
2021-07-15 4 FORM 4 SUBMISSION 0000899243-21-028495 5589
2021-07-15 3 FORM 3 SUBMISSION 0000899243-21-028493 7285
2021-07-15 8-K 8-K 5.02,9.01 0001193125-21-216388 001-36483 211092837 34 170773 1 1
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024230 5609
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024221 5624
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024220 5633
2021-06-15 8-K/A 8-K/A 5.03,5.07,9.01 0001193125-21-191326 001-36483 211019708 34 192481 1 1
2021-06-04 DEFA14A DEFA14A 0001193125-21-181948 001-36483 21994805 34 42606
2021-06-04 8-K 8-K 5.02,8.01 0001193125-21-181939 001-36483 21994796 34 159958 1 1
2021-06-01 SC 13G/A SC 13G/A 0001104659-21-074998 005-88625 21985198 34 88494
2021-05-17 8-K 8-K 5.02 0001193125-21-163642 001-36483 21930341 34 148042 1 1
2021-05-10 SC 13G SC 13G 0001104659-21-063829 005-88625 21907036 34 76657
2021-05-07 10-Q 10-Q 0001590750-21-000065 001-36483 21900082 34 6439622 1 1
2021-05-06 8-K 8-K 2.02,9.01 0001590750-21-000062 001-36483 21897807 34 279641 1 1
2021-04-30 DEF 14A DEF 14A 0001590750-21-000054 001-36483 21873915 34 1421159
2021-04-26 8-K 8-K 1.01,9.01 0001590750-21-000048 001-36483 21850814 34 651194 1 1
2021-04-23 424B3 424B3 0001590750-21-000046 333-237413 21850804 33 11787
2021-04-23 424B5 424B5 0001590750-21-000044 333-237413 21850800 33 480660
2021-04-14 PRE 14A PRE 14A 0001590750-21-000036 001-36483 21825886 34 1801837
2021-03-26 S-8 S-8 0001590750-21-000030 333-254771 21777708 33 146599
2021-03-26 10-K 10-K 0001590750-21-000029 001-36483 21777618 34 9715429 1 1
2021-03-25 8-K 8-K 2.02,9.01 0001590750-21-000023 001-36483 21772416 34 308045 1 1
2021-03-15 SC 13G/A SC 13G/A 0001104659-21-036307 005-88625 21742001 34 86230
2021-03-10 SC 13G SEC SCHEDULE 13G 0000902219-21-000345 005-88625 21728241 34 37392
2021-02-19 SC 13G SEC SCHEDULE 13G 0001645257-21-000001 005-88625 21652065 34 19137
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-024138 005-88625 21639224 34 176347
2021-02-16 SC 13G/A SCHEDULE 13G (AMENDMENT #1) 0000899140-21-000280 005-88625 21636801 34 43179
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005209 9642
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005208 9651
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005207 9671
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005206 9649
2021-02-08 4 FORM 4 SUBMISSION 0000899243-21-005204 9662
2021-01-21 3 FORM 3 SUBMISSION 0000899243-21-002779 3220
2021-01-21 4 FORM 4 SUBMISSION 0000899243-21-002770 9635
2021-01-20 4 FORM 4 SUBMISSION 0000899243-21-002488 9924
2021-01-20 4 FORM 4 SUBMISSION 0000899243-21-002484 9916
2021-01-20 8-K 8-K 5.02,5.03,8.01,9.01 0001590750-21-000013 001-36483 21537416 34 564814 1 1
2021-01-19 4 FORM 4 SUBMISSION 0000899243-21-002405 3483
2021-01-19 4 FORM 4 SUBMISSION 0000899243-21-002402 6018
2021-01-19 SC 13G schedule13g.htm 0000929638-21-000066 005-88625 21535719 34 87861
2021-01-15 4 FORM 4 SUBMISSION 0000899243-21-002233 3602
2021-01-11 SC 13G SC 13G 0001104659-21-002972 005-88625 21520897 34 163897
2021-01-11 SC 13G SC 13G 0001558370-21-000149 005-88625 21520010 34 65182
2021-01-07 SC 13G SC 13G 0001193125-21-003722 005-88625 21513001 34 132184
2021-01-05 SC 13D SC 13D 0001193125-21-001414 005-88625 21503841 34 100895
2021-01-04 8-K 8-K 5.03,5.07,8.01,9.01 0001590750-21-000003 001-36483 21501977 34 230412 1 1
2020-12-23 424B5 424B5 0001590750-20-000144 333-251367 201413372 33 609627
2020-12-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-12-22 16:01:00 9999999995-20-003637 333-251367 201409663 33 1965
2020-12-21 UPLOAD filename1.pdf 0000000000-20-012277 40437
2020-12-21 CORRESP filename1.htm 0001590750-20-000141 9582
2020-12-18 UPLOAD filename1.pdf 0000000000-20-012180 39935
2020-12-17 SC 13G SCHEDULE 13G 0001104659-20-136895 005-88625 201396571 34 88584
2020-12-17 3 OWNERSHIP DOCUMENT 0001104659-20-136892 10062
2020-12-17 8-K 8-K 1.01,3.02,7.01,9.01 0001590750-20-000138 001-36483 201394215 34 231726 1 1
2020-12-15 S-3 S-3 0001590750-20-000133 333-251367 201390272 33 728692
2020-12-14 DEF 14A DEF 14A 0001193125-20-316082 001-36483 201384799 34 1934022
2020-12-11 424B5 424B5 0001590750-20-000125 333-237413 201383993 33 598435

Latest XBRL company facts

One latest value per concept from companyfacts (430 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 113.56M 2026-11-02 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
dei EntityPublicFloat Entity Public Float USD 943.00M 2025-06-30 2025 FY 10-K 2026-02-26 0001590750-26-000007
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 7.30M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160344
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.21M 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160344
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160344
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 189.18 2025-01-01 2025-12-31 DEF 14A 2026-04-17 0001193125-26-160344
ffd NetFeeAmt NetFeeAmt USD 19,851.88 2026-05-07 424B5 2026-05-08 0001193125-26-214607
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 143.75M 2026-05-07 424B5 2026-05-08 0001193125-26-214607
ffd TtlFeeAmt TtlFeeAmt USD 19,851.88 2026-05-07 424B5 2026-05-08 0001193125-26-214607
ffd TtlOfferingAmt TtlOfferingAmt USD 143.75M 2026-05-07 424B5 2026-05-08 0001193125-26-214607
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-07 424B5 2026-05-08 0001193125-26-214607
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-07 424B5 2026-05-08 0001193125-26-214607
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 100,000 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 939,481 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 29.78M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 4.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AccretionExpense Accretion Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 15,000 2017-06-30 2017 Q2 10-Q 2017-08-11 0001193125-17-256035
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 860,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 60.76M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 7.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AccruedRentCurrent Accrued Rent, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.22M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.16B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 8.70M 2015-02-20 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 23,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 17.23M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 8.78M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD 47,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 47.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 54,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 87,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 206,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001590750-25-000012
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 40.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 10,427 2024-04-30 2024 Q2 10-Q 2024-08-08 0001590750-24-000019
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 797,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap Assets Assets USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AssetsCurrent Assets, Current USD 1.01B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 922.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 100,000 2021-12-31 2022 FY 10-K 2023-03-09 0001590750-23-000002
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 784.52M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2018-06-30 2018 Q2 10-Q 2018-08-08 0001590750-18-000018
us-gaap AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax USD 3,000 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 29.90M 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 29.90M 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 782.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 782.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap BusinessExitCosts1 Business Exit Costs USD 2.04M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 418,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 4,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 80,000 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 86,000 2015-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 7,000 2015-09-30 2015 Q3 10-Q 2015-11-13 0001171843-15-006329
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 7,000 2016-09-30 2016 Q3 10-Q 2016-10-26 0001171843-16-012638
us-gaap CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear Capital Leases, Future Minimum Payments, Remainder of Fiscal Year USD 22,000 2016-09-30 2016 Q3 10-Q 2016-10-26 0001171843-16-012638
us-gaap Cash Cash USD 10.45M 2015-06-30 2015 Q2 10-Q 2015-08-14 0001171843-15-004724
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 172.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -7.75M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 955.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 174.16M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -38.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -15.74M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001590750-18-000027
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -194,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.15 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 7.54M 2020-09-30 2020 Q3 10-Q 2020-11-12 0001590750-20-000106
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 29,446 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.54M 2020-06-30 2020 Q2 10-Q 2020-08-05 0001590750-20-000082
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 113.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 113.53M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CommonStockValue Common Stock, Value, Issued USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -335.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0001590750-25-000004
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 70.00M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 181,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001590750-26-000018
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 140,000 2025-06-30 2025 Q2 10-Q 2025-08-06 0001590750-25-000012
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 34.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 2.93M 2014-06-16 2014-06-17 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 242.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CostOfRevenue Cost of Revenue USD 1.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CostsAndExpenses Costs and Expenses USD 372.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD -3,000 2020-01-01 2020 Q1 10-Q 2020-05-08 0001590750-20-000053
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 27.33M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 2.73M 2014-06-17 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 27.30M 2014-06-17 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 6.67M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001590750-20-000053
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 182,000 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.034 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 5,320 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 27,000 2020-03-31 2020 Q1 10-Q 2020-05-08 0001590750-20-000053
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001590750-24-000007
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 0 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap DeferredFinanceCostsNoncurrentGross Debt Issuance Cost, Gross, Noncurrent USD 47,000 2014-12-31 2015 Q3 10-Q 2015-11-13 0001171843-15-006329
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 47,000 2014-12-31 2015 Q3 10-Q 2015-11-13 0001171843-15-006329
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 200,000 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 316.82M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 118.27M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 123.89M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 52,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 27.97M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 505,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 11.87M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent USD 49,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 316.82M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 0 2024-12-31 2024 FY 10-K 2025-03-03 0001590750-25-000004
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 10,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 581,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 8.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap DerivativeLiabilities Derivative Liability USD 11.62M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 11.62M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap Dividends Dividends USD 285,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 1.04M 2014-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 1.00M 2014-06-17 2014 Q2 10-Q 2014-08-14 0001171843-14-003982
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.98 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001590750-24-000023
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -2.91 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001590750-21-000065
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.98 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001590750-24-000023
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.223 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-13 0001590750-20-000021
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.057 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.002 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.05 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.022 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 22.26M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 54.90M 2022-12-31 2022 FY 10-K 2023-03-09 0001590750-23-000002
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 115.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions Share-based Payment Arrangement, Exercise of Option, Tax Benefit USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001171843-15-006329
us-gaap EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares Employee Stock Ownership Plan (ESOP), Number of Allocated Shares shares 200,000 2017-06-30 2017 Q2 10-Q 2017-08-11 0001193125-17-256035
us-gaap ExcessTaxBenefitFromShareBasedCompensationFinancingActivities Excess Tax Benefit from Share-based Compensation, Financing Activities USD -44,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD 3,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 39,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD -51,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 82,000 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 833,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 209,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 833,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 833,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 833,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 9.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap GainContingencyUnrecordedAmount Gain Contingency, Unrecorded Amount USD 100,000 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap GainLossOnContractTermination Gain (Loss) on Contract Termination USD -46,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0001590750-23-000002
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -11,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-08 0001590750-20-000053
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 100,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -4.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 61.64M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 76.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -71.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 986,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 364,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 721,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 3.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -193,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 23,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 9.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 614,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.03M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 29.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 279,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -144,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001590750-25-000012
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD 28,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 85,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -236,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 56 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 587,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-08 0001590750-24-000012
us-gaap InterestAndOtherIncome Interest and Other Income USD 14.09M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-06 0001590750-25-000012
us-gaap InterestExpense Interest Expense USD 300,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0001590750-23-000008
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 21.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 19,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-15 0001171843-15-002907
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 232,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001590750-18-000018
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap InterestPayableCurrent Interest Payable, Current USD 1.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap InventoryNet Inventory, Net USD 85,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 25.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 300,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-13 0001590750-20-000021
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.06 2021-03-31 2024 Q2 10-Q 2024-08-08 0001590750-24-000019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.16M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 965,000 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 0 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 504,000 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 854,000 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 836,000 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 237,000 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 447,000 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 200,000 2021-04-30 2022 Q2 10-Q 2022-08-15 0001590750-22-000009
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 50,000 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap Liabilities Liabilities USD 447.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap LiabilitiesCurrent Liabilities, Current USD 70.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 11.62M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 4.76M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001590750-18-000012
us-gaap LitigationSettlementAmount Litigation Settlement, Amount (Deprecated 2017-01-31) USD 350,000 2013-08-01 2013-08-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap LongTermDebt Long-term Debt USD 20.33M 2024-03-31 2024 Q1 10-Q 2024-05-08 0001590750-24-000012
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 8.44M 2025-06-30 2025 Q2 10-Q 2025-08-06 0001590750-25-000012
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 4.00M 2019-12-31 2019 FY 10-K 2020-03-13 0001590750-20-000021
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 3.67M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001590750-18-000027
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 3.67M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 3.67M 2019-12-31 2019 FY 10-K 2020-03-13 0001590750-20-000021
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 1.00M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 20.89M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap LongTermInvestments Long-term Investments USD 0 2020-09-30 2020 Q3 10-Q 2020-11-12 0001590750-20-000106
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001590750-17-000010
us-gaap MembersEquity Members' Equity USD -23.89M 2013-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 409.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -129.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -317.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -333.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -25.69M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001590750-22-000007
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -25.69M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-13 0001590750-22-000007
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 164,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 12.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap NotesIssued1 Notes Issued USD 20.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap NotesPayable Notes Payable USD 7.37M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001590750-20-000053
us-gaap NotesPayableCurrent Notes Payable, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap NotesPayableFairValueDisclosure Notes Payable, Fair Value Disclosure USD 42,000 2013-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 1.04M 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap NotesReduction Notes Reduction USD 20.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OperatingExpenses Operating Expenses USD 242.86M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001590750-26-000018
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -345.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OperatingLeaseCost Operating Lease, Cost USD 300,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.71M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 806,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.90M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap OperatingLeasePayments Operating Lease, Payments USD 300,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.65M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 379,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 102,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 277,000 2017-09-30 2017 Q3 10-Q 2017-11-09 0001590750-17-000010
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 277,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001590750-18-000027
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 277,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 95,000 2017-09-30 2017 Q3 10-Q 2017-11-09 0001590750-17-000010
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 240,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.092 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 104.10M 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 7.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 131,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 255,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0001590750-25-000008
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -22,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -2.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax USD -233,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-09 0001590750-23-000002
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -2.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherExpenses Other Expenses USD 166,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap OtherFiniteLivedIntangibleAssetsGross Other Finite-Lived Intangible Assets, Gross USD 10.00M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001590750-26-000018
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 4,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.23M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 121.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -169,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001590750-26-000012
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -47,000 2019-10-01 2019-12-31 2019 FY 10-K 2020-03-13 0001590750-20-000021
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -582,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 75.00M 2026-06-30 2026 Q2 10-Q 2026-08-06 0001590750-26-000018
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 13.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 2,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.47M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001590750-20-000106
us-gaap PaymentsOfCapitalDistribution Payments of Capital Distribution USD 285,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001590750-25-000004
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 8.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 8.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 171,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 645.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap PaymentsToAcquireEquipmentOnLease Payments to Acquire Equipment on Lease USD 136,000 2014-12-01 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 67.38M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001590750-21-000070
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments Pledged Assets, Not Separately Reported, Other USD 275,000 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 5,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2021-06-30 2021 Q2 10-Q 2021-08-12 0001590750-21-000070
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2021-06-30 2021 Q2 10-Q 2021-08-12 0001590750-21-000070
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2021-06-30 2021 Q2 10-Q 2021-08-12 0001590750-21-000070
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 26.76M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 250.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 289.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 75.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 28.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 143.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-15 0001590750-18-000006
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 15.00M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001590750-24-000007
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements USD 100,000 2015-01-01 2015-01-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 46.86M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 795,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans Proceeds from Repayment of Loans by Employee Stock Ownership Plans USD 12,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-05 0001590750-21-000075
us-gaap ProceedsFromRepaymentsOfRestrictedCashFinancingActivities Proceeds from (Repayments of) Restricted Cash, Financing Activities USD 50,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 527.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 67.04M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001590750-21-000070
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 100,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-09 0001590750-23-000002
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001590750-24-000007
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 10.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.88M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0001590750-24-000007
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.63M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.44M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 74,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-05 0001590750-21-000075
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.08 2014-01-01 2014-06-17 2014 Q2 10-Q 2014-08-14 0001171843-14-003982
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 84,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 54.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 10.46M 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.05M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001590750-20-000106
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 219.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 50,000 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 50,000 2014-12-31 2014 FY 10-K 2015-03-27 0001171843-15-001691
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings Restricted Stock, Shares Issued Net of Shares for Tax Withholdings shares 154,968 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-10-26 0001171843-16-012638
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD -171,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 2.40M 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 1.50M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001590750-19-000059
us-gaap RestructuringAndRelatedCostExpectedCostRemaining1 Restructuring and Related Cost, Expected Cost Remaining USD 0 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated Restructuring and Related Cost, Expected Number of Positions Eliminated position 44 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001590750-20-000106
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.5 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap RestructuringCharges Restructuring Charges USD 300,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap RestructuringReserve Restructuring Reserve USD 0 2020-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap RestructuringReserveAccrualAdjustment1 Restructuring Reserve, Accrual Adjustment USD 41,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001590750-20-000106
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 1.75M 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.67B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 26.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 28,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001590750-18-000012
us-gaap Revenues Revenues USD 4.16M 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-15 0001171843-16-011777
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 783,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap RoyaltyExpense Royalty Expense USD 86,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap RoyaltyGuaranteesCommitmentsAmount Royalty Guarantees, Commitments, Amount USD 30,000 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap SaleOfStockConsiderationReceivedPerTransaction Sale of Stock, Consideration Received Per Transaction USD 50.00M 2017-03-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001590750-18-000018
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 170,502 2019-12-01 2019-12-31 2020 FY 10-K 2021-03-26 0001590750-21-000029
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 4.78M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001590750-18-000012
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap SecurityDeposit Security Deposit USD 15,000 2015-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 1.67M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 151.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 47.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2014-07-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001171843-14-005571
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 1.39M 2020-01-01 2020 Q2 10-Q 2020-08-05 0001590750-20-000082
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 4.18M 2016-12-31 2020 Q2 10-Q 2020-08-05 0001590750-20-000082
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 6.42M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 69.06M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.03M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 17.74 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 8.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 1.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 770,843 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 209.09M 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 16.52M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.82 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 2.42M 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 1.98M 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 4.2 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.70M 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 3.53M 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.76 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 39.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 14.84 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 23.33 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 20.51 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 16.32 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity USD 330,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001171843-15-006329
us-gaap SharePrice Share Price USD/shares 42 2015-02-20 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap ShortTermInvestments Short-term Investments USD 144.57M 2022-03-31 2022 Q1 10-Q 2022-05-13 0001590750-22-000007
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 580.70M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 2.93M 2014-06-17 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 214,286 2015-02-20 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 811,970 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 95.36M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 2.19M 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-21 0001171843-16-008702
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.27M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 5.69M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 134.97M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 547,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001590750-25-000020
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.63M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 2,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001171843-17-001747
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001590750-19-000013
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 479,000 2021-09-30 2021 Q3 10-Q 2021-11-05 0001590750-21-000075
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -300,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-03 0001590750-25-000004
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense Unrecognized Tax Benefits, Income Tax Penalties Expense USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001590750-22-000004
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued Unrecognized Tax Benefits, Interest on Income Taxes Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 108.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001590750-26-000007
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 81.58M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001590750-26-000022
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 6.34M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001590750-21-000065
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 63.80M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-12 0001590750-24-000023

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →